𝔖 Bobbio Scriptorium

✦ LIBER ✦

11 VALIDATION OF CLINICAL PARAMETERS ON THE 15-YEAR LONG-TERM OUTCOME OF A TRIMODALITIY TREATMENT AND SELECTIVE ORGAN PRESERVATION FOR INVASIVE BLADDER CANCER

✍ Scribed by F.S. Krause; O. Ott; L. Haeberle; B. Wullich

Book ID: 119620756
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 76 KB
Volume: 9
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(10)60019-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: Jason A. Efstathiou, Daphna Y. Spieg

Re: Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, et al. Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience. Eur Urol 2012;61:705–11

✍ Neeraj Kumar Goyal; Manish Garg; Apul Goel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

7171 Chemoradiotherapy with cisplatin (C

7171 Chemoradiotherapy with cisplatin (C) and gemcitabine (G) plus concurrent irradiation (XRT), for the conservative treatment of invasive transitional bladder cancer (ITBC) patients – clinical outcome and long term follow-up in a monoinstitutional experience

✍ Caffo, O.; Fellin, G.; Graffer, U.; Mussari, S.; Arcuri, C.; Caldara, A.; Murgia 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Reply to Neeraj Kumar Goyal, Manish Garg

Reply to Neeraj Kumar Goyal, Manish Garg, and Apul Goel's Letter to the Editor re: Re: Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley, et al. Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience. Eur Urol 2012;61:705–11

✍ Jason A. Efstathiou; William U. Shipley; Anthony L. Zietman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Commentary on “International phase III t

Commentary on “International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: Long-term results of the BA06 30894 trial.” Griffiths G, Hall R, Sylvester R, Raghavan D, Parmar MK, and the International Collaboration of Trialists; Medical Research Council Advanced Bladder Cancer Working Party (now the National Cancer Research Institute Bladder Cancer Clinical Studies Group); European Organization for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group; Australian Bladder Cancer Study Group; National Cancer Institute of Canada Clinical Trials Group; Finnbladder; Norwegian Bladder Cancer Study Group; Club Urologico Espanol de Tratamiento Oncologico Group. Medical Research Council Clinical Trials Unit, London, United Kingdom: J Clin Oncol 2011;29:2171–7

✍ H. Barton Grossman 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB